艾思科蓝公众号
您当前浏览器版本过低,为了不影响您的使用,建议您使用最新的谷歌浏览器、火狐浏览器、 360浏览器,更换浏览器后使用更流畅!(注意!双核浏览器请切换为极速模式)
转发
| SCI期刊JCR分区 |
SCI期刊JCR分区等级:2区
|
||||||||||||||
|
《新锐期刊分区表》
(2026年3月发布)
|
|
||||||||||||||
|
最新中科院SCI期刊分区
(2025年3月升级版)
|
|
||||||||||||||
|
期刊简介
|
|
|
Statistics in Biopharmaceutical Research ( SBR), publishes articles that focus on the needs of researchers and applied statisticians in biopharmaceutical industries; academic biostatisticians from schools of medicine, veterinary medicine, public health, and pharmacy; statisticians and quantitative analysts working in regulatory agencies (e.g., U.S. Food and Drug Administration and its counterpart in other countries); statisticians with an interest in adopting methodology presented in this journal to their own fields; and nonstatisticians with an interest in applying statistical methods to biopharmaceutical problems. Statistics in Biopharmaceutical Research accepts papers that discuss appropriate statistical methodology and information regarding the use of statistics in all phases of research, development, and practice in the pharmaceutical, biopharmaceutical, device, and diagnostics industries. Articles should focus on the development of novel statistical methods, novel applications of current methods, or the innovative application of statistical principles that can be used by statistical practitioners in these disciplines. Areas of application may include statistical methods for drug discovery, including papers that address issues of multiplicity, sequential trials, adaptive designs, etc.; preclinical and clinical studies; genomics and proteomics; bioassay; biomarkers and surrogate markers; models and analyses of drug history, including pharmacoeconomics, product life cycle, detection of adverse events in clinical studies, and postmarketing risk assessment; regulatory guidelines, including issues of standardization of terminology (e.g., CDISC), tolerance and specification limits related to pharmaceutical practice, and novel methods of drug approval; and detection of adverse events in clinical and toxicological studies. Tutorial articles also are welcome. Articles should include demonstrable evidence of the usefulness of this methodology (presumably by means of an application). The Editorial Board of SBR intends to ensure that the journal continually provides important, useful, and timely information. To accomplish this, the board strives to attract outstanding articles by seeing that each submission receives a careful, thorough, and prompt review. Authors can choose to publish gold open access in this journal.
|
|
出版信息
|
|
| 出版商 | Taylor and Francis Ltd. |
| 期刊官网 | https://www.tandfonline.com/journals/usbr20 |
| 涉及的研究方向 | MATHEMATICAL & COMPUTATIONAL BIOLOGY-STATISTICS & PROBABILITY |
| 刊期 | Quarterly |
| 年文章数 | 52 |
| 出版国家或地区 | UNITED STATES |
| 是否OA | 否 |
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) |
|
Cite Score相关
|
|||||||||||||||
|
Cite Score
(2025年最新版)
|
|
||||||||||||||
立即投稿
立即投稿
立即投稿
立即投稿
立即投稿
立即投稿
立即投稿
立即投稿
推荐会议
IEEE Xplore,EI,Scopus
【中大主办 | IEEE出版 | 往届2.5个月检索】第六届计算机科学与区块链国际学术会议(CCSB 2026)


会议时间:2026-08-21
截稿时间:2026-08-07
EI,Scopus,IEEE Xplore
【8.7最终截稿 | IEEE丨往届2个月EI检索】第七届物联网、人工智能与电气能源国际学术会议(IoTAIEE 2026)


会议时间:2026-08-21
截稿时间:2026-08-07
EI,Scopus,IEEE Xplore
【IEEE出版|往届3.5个月检索】第八届人工智能技术与应用国际学术会议(ICAITA 2026)


会议时间:2026-08-21
截稿时间:2026-08-07
EI,Scopus
【年度重磅会议/多位院士报告/EI快检索】第七届先进材料与智能制造国际学术会议(ICAMIM 2026)


会议时间:2026-08-28
截稿时间:2026-08-14
EI,Scopus
【SPIE出版,往届已EI检索 | SCIE期刊同步征稿】第六届智能交通系统与智慧城市国际学术会议(ITSSC 2026)


会议时间:2026-08-28
截稿时间:2026-08-05
IEEE Xplore,EI,Scopus
【IEEE冠名/7月31日24点截稿/电子科大主办】第五届IEEE电子信息技术国际学术会议(EIT 2026)


会议时间:2026-08-28
截稿时间:2026-08-14
EI,Scopus,IEEE Xplore
【IEEE出版|北京交通大学主办】第六届电子信息工程与计算机技术国际学术会议(EIECT 2026)


会议时间:2026-09-04
截稿时间:2026-08-21
EI,Scopus
【IEEE出版|沈阳理工大学主办】第五届机械电子工程与人工智能国际学术会议(MEAI 2026)


会议时间:2026-09-11
截稿时间:2026-08-08